162 related articles for article (PubMed ID: 2354416)
1. Neuron specific enolase (NSE) in serum of patients with malignant melanoma.
Wibe E; Paus E; Aamdal S
Cancer Lett; 1990 Jun; 52(1):29-31. PubMed ID: 2354416
[TBL] [Abstract][Full Text] [Related]
2. Neuron-specific enolase as a prognostic factor in metastatic malignant melanoma.
Wibe E; Hannisdal E; Paus E; Aamdal S
Eur J Cancer; 1992; 28A(10):1692-5. PubMed ID: 1389487
[TBL] [Abstract][Full Text] [Related]
3. Neuron-specific enolase as a tumor marker in metastatic melanoma.
Buzaid AC; Sandler AB; Hayden CL; Scinto J; Poo WJ; Clark MB; Hotchkiss S
Am J Clin Oncol; 1994 Oct; 17(5):430-1. PubMed ID: 8092117
[TBL] [Abstract][Full Text] [Related]
4. Immunoradiometric assay of chromogranin A in the diagnosis of small cell lung cancer: comparative evaluation with neuron-specific enolase.
Giovanella L; Ceriani L; Bandera M; Garancini S
Int J Biol Markers; 2001; 16(1):50-5. PubMed ID: 11288956
[TBL] [Abstract][Full Text] [Related]
5. Immunoradiometric assay for alpha gamma- and gamma gamma-enolase (neuron-specific enolase), with use of monoclonal antibodies and magnetizable polymer particles.
Paus E; Nustad K
Clin Chem; 1989 Oct; 35(10):2034-8. PubMed ID: 2551540
[TBL] [Abstract][Full Text] [Related]
6. Serum neuron-specific enolase is a useful tumor marker for small cell lung cancer.
Burghuber OC; Worofka B; Schernthaner G; Vetter N; Neumann M; Dudczak R; Kuzmits R
Cancer; 1990 Mar; 65(6):1386-90. PubMed ID: 2155054
[TBL] [Abstract][Full Text] [Related]
7. S-100 and NSE as serum markers in melanoma.
Tofani A; Cioffi RP; Sciuto R; Rea S; Festa A; Di Filippo F; Cavaliere R; Maini CL
Acta Oncol; 1997; 36(7):761-4. PubMed ID: 9490097
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of serum S100 in metastatic malignant melanoma.
Guo HB; Stoffel-Wagner B; Bierwirth T; Mezger J; Klingmüller D
Eur J Cancer; 1995 Oct; 31A(11):1898-902. PubMed ID: 8541129
[TBL] [Abstract][Full Text] [Related]
9. Monoclonal immunoradiometric assay and polyclonal radioimmunoassay compared for measuring neuron-specific enolase in patients with lung cancer.
Body JJ; Paesmans M; Sculier JP; Dabouis G; Bureau G; Libert P; Berchier MC; Raymakers N; Klastersky J
Clin Chem; 1992 May; 38(5):748-51. PubMed ID: 1316245
[TBL] [Abstract][Full Text] [Related]
10. Neuron-specific enolase can be used as the sole guide to treat small-cell lung cancer patients in common clinical practice.
Splinter TA; Carney DN; Teeling M; Peake MD; Kho GS; Oosterom R; Cooper EH
J Cancer Res Clin Oncol; 1989; 115(4):400-1. PubMed ID: 2547802
[TBL] [Abstract][Full Text] [Related]
11. Neuron-specific enolase--a serum tumour marker in seminoma?
Fosså SD; Klepp O; Paus E
Br J Cancer; 1992 Feb; 65(2):297-9. PubMed ID: 1739633
[TBL] [Abstract][Full Text] [Related]
12. Pro-gastrin-releasing peptide and neuron-specific enolase: useful predictors of response to chemotherapy and survival in patients with small cell lung cancer.
Huang Z; Xu D; Zhang F; Ying Y; Song L
Clin Transl Oncol; 2016 Oct; 18(10):1019-25. PubMed ID: 26886220
[TBL] [Abstract][Full Text] [Related]
13. [Neuron-specific enolase: a serum marker of clinical progression for metastatic malignant melanoma].
Guo HB; Stoffel-Wagner B; Brennemann W; Springer W; Klingmüller D
J Tongji Med Univ; 1995; 15(1):19-25. PubMed ID: 7783258
[No Abstract] [Full Text] [Related]
14. Neurone specific enolase (NSE) in small cell lung cancer: a tumour marker of prognostic significance?
Harding M; McAllister J; Hulks G; Vernon D; Monie R; Paul J; Kaye SB
Br J Cancer; 1990 Apr; 61(4):605-7. PubMed ID: 2158809
[TBL] [Abstract][Full Text] [Related]
15. Normal serum neuron specific enolase (NSE) value after the first cycle of chemotherapy: an early predictor of complete response and survival in patients with small cell lung carcinoma.
Fizazi K; Cojean I; Pignon JP; Rixe O; Gatineau M; Hadef S; Arriagada R; Baldeyrou P; Comoy E; Le Chevalier T
Cancer; 1998 Mar; 82(6):1049-55. PubMed ID: 9506348
[TBL] [Abstract][Full Text] [Related]
16. [Neuron-specific enolase and beta 2-microglobulin in the serum of patients with melanoma].
Uerlich M; Biltz H; Kreysel HW
Immun Infekt; 1988 Apr; 16(2):65-7. PubMed ID: 3292403
[TBL] [Abstract][Full Text] [Related]
17. High Serum Neuron-Specific Enolase (NSE) Level Firstly Ignored as Normal Reaction in a Small Cell Lung Cancer Patient: a Case Report and Literature Review.
Ge YL; Liu CH; Wang MH; Zhu XY; Zhang Q; Li ZZ; Li HL; Cui ZY; Zhang HF; Zhang X; Yu HL; Fu AS; Wang HY
Clin Lab; 2019 Jan; 65(1):. PubMed ID: 30775876
[TBL] [Abstract][Full Text] [Related]
18. [Neuron-specific enolase (NSE)--a suitable tumor marker in malignant melanoma?].
Hornef S; Lux J; Rassner G
Hautarzt; 1992 Feb; 43(2):77-80. PubMed ID: 1347764
[TBL] [Abstract][Full Text] [Related]
19. Enzyme-linked immunosorbent assay of pro-gastrin-releasing peptide for small cell lung cancer patients in comparison with neuron-specific enolase measurement.
Yamaguchi K; Aoyagi K; Urakami K; Fukutani T; Maki N; Yamamoto S; Otsubo K; Miyake Y; Kodama T
Jpn J Cancer Res; 1995 Jul; 86(7):698-705. PubMed ID: 7559089
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of serum S100 in metastatic malignant melanoma.
Guo HB; Stoffel-Wagner B; Bierwirth T; Mezger J; Klingmüller D
Eur J Cancer; 1995 Jun; 31A(6):924-8. PubMed ID: 7646923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]